Company Filing History:
Years Active: 2017
Title: David Hardem: Innovator in Medicinal Chemistry
Introduction
David Hardem is a notable inventor based in Sutton Bonington, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on triazolo(4,5-D)pyrimidine compounds. His research has implications for the development of new medicaments.
Latest Patents
David Hardem holds one patent for his invention titled "Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation." The compounds of this invention are characterized by a specific formula, wherein R, X, and R through R are defined in the specification. This patent highlights the potential therapeutic applications of these compounds.
Career Highlights
David Hardem is associated with Astra Zeneca U.K. Limited, a leading pharmaceutical company. His work at Astra Zeneca has allowed him to focus on the development of innovative medicinal compounds that can address various health challenges.
Collaborations
David has collaborated with notable colleagues, including Anthony Howard Ingall and Brian Springthorpe. These collaborations have contributed to the advancement of research in medicinal chemistry and the development of new therapeutic agents.
Conclusion
David Hardem's contributions to the field of medicinal chemistry through his innovative patents and collaborations underscore his role as a significant inventor. His work continues to influence the development of new medicaments that may benefit public health.